Clinical Study
Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension in Noncirrhotic Patients with Portal Cavernoma
Table 1
Patient characteristics, previous history of splenectomy, imaging studies, and laboratory results.
| Patient number/age (y)/sex | Underlying prothrombotic disorders | Imaging studies | TBIL (μmol/L) | ALT (U/L) | AST (U/L) | ALP (U/L) | WBC (109/L) | Platelet (109/L) | Splenectomy |
| 1/35/F | N/A | Total occluded MPV and SMV | 10.2 | 12 | 15 | 79 | 4.94 | 122 | Yes |
| 2/24/M | N/A | Partial occluded MPV | 9.4 | 23 | 50 | 73 | 2.76 | 45 | Yes |
| 3/39/M | N/A | Total occluded MPV and SV and partial occluded SMV | 11.3 | 11 | 25 | 75 | 9.77 | 6 | No |
| 4/19/M | Antithrombin III deficiency, thrombocytosis | Total occluded MPV | 15.3 | 57 | 86 | 59 | 1.83 | 472 | Yes |
| 5/25/F | Protein C deficiency, antithrombin III deficiency | Total occluded MPV and partial occluded SMV and SV | 36.4 | 37 | 32 | 166 | 4.37 | 25 | No |
| 6/26/M | N/A | Partial occluded MPV | 10.4 | 17 | 25 | 112 | 2.51 | 71 | Yes |
| 7/25/F | Thrombocytosis | Total occluded MPV | 6.4 | 29 | 33 | 70 | 2.63 | 653 | Yes |
| 8/40/M | Antithrombin III deficiency | Partial occluded MPV | 7.7 | 19 | 26 | 96 | 4.17 | 216 | No |
| 9/21/F | No | Total occluded MPV and SMV | 15.6 | 29 | 19 | 101 | 14.26 | 185 | Yes |
| 10/19/M | Antithrombin III deficiency | Total occluded MPV and partial occluded SMV | 19.6 | 16 | 33 | 68 | 3.41 | 51 | No |
| 11/34/M | Protein C deficiency | Total occluded MPV, partial occluded SMV and SV | 13.8 | 13 | 26 | 72 | 2.42 | 52 | No |
| 12/45/M | No | Total occluded MPV and SMV | 19 | 13 | 21 | 145 | 2.15 | 277 | Yes |
| 13/31/M | Thrombocytosis | Total occluded MPV and SMV | 10.8 | 15 | 23 | 67 | 1.27 | 517 | Yes |
| 14/29/M | FVL mutation, protein C deficiency | Total occluded MPV and partial occluded SMV | 6 | 26 | 24 | 63 | 3.54 | 189 | Yes |
| 15/24/M | Protein S deficiency | Partial occluded MPV | 8.1 | 10 | 16 | 38 | 7.68 | 92 | No |
|
|
TBIL: total bilirubin, ALT: alanine aminotransferase, AST: aspartate aminotransferase, ALP: alkaline phosphatase, WBC: white blood cell, MPV: main portal vein, SMV: superior mesenteric vein, SV: splenic vein, and FVL mutation: Factor V Leiden mutation.
|